Influenza vaccine coverage and the attack rate of influenza-like illness among the elderly in Portugal: is there a correlation? by Nunes, Baltazar et al.
 Eurosurveillance, Volume 12, Issue 20, 17 May 2007  
Articles 
Citation style for this article: Nunes B, Falcao I, Machado A, Rodrigues E, Marinho Falcao J. Influenza vaccine coverage and the 
attack rate of influenza-like illness among the elderly in Portugal: is there a correlation?. Euro Surveill. 2007;12(20):pii=3195. 
Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3195 
Influenza vaccine coverage and the attack rate of influenza-like illness among the 
elderly in Portugal: is there a correlation?  
B Nunes (Baltazar.Nunes@insa.min-saude.pt), I Falcão, A Machado, E Rodrigues, J Marinho Falcão 
Instituto Nacional de Saúde Dr. Ricardo Jorge, Observatório Nacional de Saúde (National Institute 
of Health Dr Ricardo Jorge, National Observatory of Health), Lisbon, Portugal  
Vaccination of the elderly (>=65 years of age) against influenza is recommended in all European 
countries and believed to significantly reduce influenza-related morbidity and mortality [1]. 
However, there have been relatively few studies on the relationship between the vaccine coverage 
and the attack rate of influenza-like illness (ILI), and their results have differed [2,3,4].  
The study described in this paper aimed at establishing the correlation between the influenza 
vaccine coverage rates and the rates of ILI among Portuguese population aged 65 years and 
older, during the influenza seasons 1998-1999 to 2006-2007. 
Methodology  
Influenza vaccine coverage rates  
The influenza vaccine coverage rates were obtained from ECOS (Em Casa Observamos Saúde - At 
Home We Watch Health) [5], a survey of approximately 1,000 households carried out by 
computer-assisted telephone interview (CATI) [6]. These households were selected randomly from 
the national telephone directory and recruited considering the representativity of mainland 
Portuguese families with telephone.  
The influenza vaccination surveys, for each influenza season, have been carried out every spring 
since 1999. In each household, information on the vaccine uptake was obtained from one 
respondent (aged 18 years or more) on him- or herself and his or her cohabitants. Vaccine 
coverage estimates are available for the seasons between 1998/1999 and 2006/2007 (with the 
exception of the 1999/2000 season) by age groups for the country and for each region in Portugal. 
In this study, we used the data on vaccine coverage of the respondents aged 65 years or older, 
resident in mainland Portugal.  
ILI attack rates  
The data on ILI attack rates were obtained from the Portuguese Sentinel Network Médicos-
Sentinela (MS). In Portugal, general practitioners (GPs) have been collaborating continuously on 
influenza surveillance since 1990, providing clinical data to the National Observatory of Health on 
a weekly basis. The number of new episodes of influenza occurring in patients on the GPs’ lists is 
available for the last 18 years, as well as the weekly estimates of the ILI incidence rate (per 
100,000 inhabitants) by age group and sex for the whole country [7].  
For the purpose of our study, attack rates were obtained by summing up all weekly ILI incidence 
rates for the period between week 40 (beginning of October) and week 14 of the next year (end of 
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rates for the period between week 40 (beginning of October) and week 14 of the next year (end of 
March) (cumulative incidence rate).  
The incidence rates calculated through the GP sentinel network are believed to be underestimated 
for several reasons, such as patients do not always seek medical assistance when ill with ILI or 
they consult another doctor or health service. Therefore, a correction of the seasonal attack rates 
was introduced using the proportion of 0.30 ILI patients aged 65 years and older that consult their 
GPs, obtained from a previous study [8]. The association between the corrected attack rate for the 
period defined above (week 40 to week 14) with vaccine coverage was measured by the Pearson 
and Spearman correlation coefficients. Note that since the correction factor is constant for all the 
seasons in the study, the correlation coefficients obtained are not affected. A linear time trend was 
evaluated for values of vaccine coverage and attack rate for the study period (1998-1999 to 2006-
2007) through correlation coefficients.  
All results were obtained with the use of statistics program package SPSS 14.0.  
Results  
For the period between 1998-1999 and 2006-2007, no statistically significant linear time trends 
for vaccine coverage or attack rate were found, indicating that there was no evolution pattern in 
these parameters during the study period.  
The table and figure below show the relation between vaccine coverage and attack rate among the 
Portuguese population aged 65 years and older during the study period. From the analysis of 
these results, and without taking into consideration the dominant sub-type of virus, the correlation 
between vaccine coverage and attack rate was very weak and not statistically significant - Pearson 
r=-0.534, p=0.173; Spearman rs=-0.359, p=0.382) (in 8 seasons). On the other hand, restricting 
the analysis to the A(H3) influenza dominant sub-type virus (in 6 seasons), a negative linear 
correlation was found between vaccine coverage and attack rate - Pearson r=-0.911, p=0.011; 
Spearman rs=-0.899, p=0.015, suggesting a concomitant variation of vaccine coverage and 
attack rate.  
Table. Vaccine coverage rates and ILI attack rates in the age group >=65 years, and dominant 
sub-type virus for seasons 1998-1999 to 2006-2007, Portugal  
n.a. - not available 
* B, A(H1): no season-dominant sub type of virus [10]. 
Figure. Scatter plot of the vaccine coverage rates versus the ILI attack rates in the age group >= 
Season
Vaccine coverage 
(%)
Attack rate 
(%)
Dominant sub-type of 
virus [9]
1998-
1999
31.3 5.96 A(H3)
1999-
2000
39 3.78 A(H3)
2000-
2001
n.a. 1.81 B
2001-
2002
41.9 4.4 A(H3)
2002-
2003
36.9 2.01 B
2003-
2004
46.9 3.47 A(H3)
2004-
2005
39 5.37 A(H3)
2005-
2006
41.6 1.78 B, A(H1)*
2006-
2007
50.4 2.21 A(H3)
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Figure. Scatter plot of the vaccine coverage rates versus the ILI attack rates in the age group >= 
65 years according to the dominant sub-type virus for seasons 1998-1999 to 2006-2007  
  
Conclusion  
In this study, conducted on the Portuguese population aged 65 years and older, a negative linear 
correlation was found between the vaccine coverage and the ILI attack rate, in seasons with A(H3) 
dominant sub-type virus.  
Considering all the seasons together, no significant correlation between vaccine coverage and the 
ILI attack rates was found, probably because ILI attack rates during the A(H3)-dominant seasons 
are usually higher than those associated with other dominant types of virus, which increases the 
data dispersion. On the other hand, as the non A(H3)-dominant seasons were only two, no 
correlation coefficient was calculated.  
The season attack rates were obtained by summing up all the weekly ILI incidence rates, obtained 
with clinical diagnosed cases, including some without virological confirmation. This may have led 
to an underestimation of the correlation coefficients, although the authors consider it unlikely as 
the obtained coefficients are so high that any underestimation would be irrelevant. This limitation 
could be overcome by considering only the rates calculated with laboratory-confirmed cases. This 
has not been done given the instability of the rate estimates caused by the small proportion (and 
absolute number) of cases with a laboratory-confirmed diagnosis.  
Although this is an ecological study, with known limitations (the data is not individual-based and 
potential confounders are not available precluding the possibility of adjustment), the results 
suggest an impact of vaccine coverage on attack rates of ILI, in the elderly, at least in seasons 
with A(H3) dominant sub-type virus. Hence the authors considered it useful to report these results 
and thus contribute to the discussion on the impact of influenza vaccine coverage in reducing the 
burden of disease at a community level across Europe.  
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